Central carbon metabolism drives critical cellular processes, including energy transduction, redox balance and the generation of molecular building blocks. However, these processes can be disrupted in a wide range of diseases, including diabetes, heart disease, microbial infections and cancer. Metabolomics is uniquely placed to explore these altered metabolic states but has a number of major technical challenges including providing comprehensive and reliable quantitative coverage of highly polar and ionic metabolites which make up the majority of the metabolites in primary metabolic pathways.
We have been advancing IC-MS techniques for both targeted and untargeted metabolomics applications. Our focus is the comprehensive analysis of highly polar and ionic metabolites from cells, tissues, and bio-fluid extracts to provide deeper insights into the metabolic alterations associated with disease states (Walsby-Tickle et al., Comms. Biol., 2020).